Analystreport

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating.

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report